Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Sentinel node (SLN) biopsy in the management of locally advanced cervical cancer

D. Cibula, D. Kužel, J. Sláma, D. Fischerová, P. Dundr, P. Freitag, M. Zikán, D. Pavlišta, V. Tomancová

. 2009 ; 115 (1) : 46-50.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu financování organizované

Perzistentní odkaz   https://www.medvik.cz/link/bmc11019483

Grantová podpora
NS10037 MZ0 CEP - Centrální evidence projektů

OBJECTIVES: Sentinel lymph node (SLN) biopsy can significantly contribute to the management of locally advanced cervical cancers with high risk of lymph node (LN) positivity. However, low detection rate and sensitivity were reported in larger tumors, albeit on a small number of cases. It was the aim of our study to verify the SLN reliability in large tumors, with modified dye application technique and a careful identification of side-specific lymphatic drainage. METHODS: The study involved 44 patients with tumors 3 cm in diameter or larger, stages IB1 to IIA, or selected IIB. In cases where SLN could not be detected, systematic pelvic lymphadenectomy was performed on the respective side. Systematic pelvic lymphadenectomy was performed during the second step radical procedure if not already done. RESULTS: Detection rate in the whole cohort reached 77% per patient and 59% bilaterally. No significant difference was found whether a blue dye or a combined method was used (75% vs 80%, and 55% vs 67%). Systematic pelvic lymphadenectomy was performed in cases with undetected SLN unilaterally in 8 and bilaterally in 10 women. A systematic pelvic lymphadenectomy was included in the second step radical procedure in 19 cases and no positive LN were found. There was no case of false-negative SLN result in patients who underwent surgical treatment. CONCLUSION: Detection rate in locally advanced cervical cancer could be improved by a careful dye application technique. Low false-negative SLN rate could be achieved if pelvic lymphatic drainage is evaluated on a side-specific principle by performing systematic lymphadenectomy if SLN is not detected.

Citace poskytuje Crossref.org

000      
03571naa 2200517 a 4500
001      
bmc11019483
003      
CZ-PrNML
005      
20140328110058.0
008      
110714s2009 xxu e eng||
009      
AR
024    __
$a 10.1016/j.ygyno.2009.06.017 $2 doi
035    __
$a (PubMed)19646741
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Cibula, David, $d 1968- $7 jo20000074072
245    10
$a Sentinel node (SLN) biopsy in the management of locally advanced cervical cancer / $c D. Cibula, D. Kužel, J. Sláma, D. Fischerová, P. Dundr, P. Freitag, M. Zikán, D. Pavlišta, V. Tomancová
314    __
$a Department of Obstetrics and Gynecology, General Teaching Hospital in Prague, First Medical School, Charles University, Oncogynecological Center, Prague 2, Czech Republic. david.cibula@iol.cz
520    9_
$a OBJECTIVES: Sentinel lymph node (SLN) biopsy can significantly contribute to the management of locally advanced cervical cancers with high risk of lymph node (LN) positivity. However, low detection rate and sensitivity were reported in larger tumors, albeit on a small number of cases. It was the aim of our study to verify the SLN reliability in large tumors, with modified dye application technique and a careful identification of side-specific lymphatic drainage. METHODS: The study involved 44 patients with tumors 3 cm in diameter or larger, stages IB1 to IIA, or selected IIB. In cases where SLN could not be detected, systematic pelvic lymphadenectomy was performed on the respective side. Systematic pelvic lymphadenectomy was performed during the second step radical procedure if not already done. RESULTS: Detection rate in the whole cohort reached 77% per patient and 59% bilaterally. No significant difference was found whether a blue dye or a combined method was used (75% vs 80%, and 55% vs 67%). Systematic pelvic lymphadenectomy was performed in cases with undetected SLN unilaterally in 8 and bilaterally in 10 women. A systematic pelvic lymphadenectomy was included in the second step radical procedure in 19 cases and no positive LN were found. There was no case of false-negative SLN result in patients who underwent surgical treatment. CONCLUSION: Detection rate in locally advanced cervical cancer could be improved by a careful dye application technique. Low false-negative SLN rate could be achieved if pelvic lymphatic drainage is evaluated on a side-specific principle by performing systematic lymphadenectomy if SLN is not detected.
590    __
$a bohemika - dle Pubmed
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a barvicí látky $x diagnostické užití $7 D004396
650    _2
$a falešně pozitivní reakce $7 D005189
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a laparoskopie $7 D010535
650    _2
$a lymfadenektomie $7 D008197
650    _2
$a lymfatické uzliny $x chirurgie $x patologie $7 D008198
650    _2
$a lidé středního věku $7 D008875
650    _2
$a staging nádorů $7 D009367
650    _2
$a rosanilinová barviva $x diagnostické užití $7 D012394
650    _2
$a biopsie sentinelové lymfatické uzliny $x metody $x normy $7 D021701
650    _2
$a nádory děložního čípku $x chirurgie $x patologie $7 D002583
650    _2
$a mladý dospělý $7 D055815
655    _2
$a financování organizované $7 D005381
700    1_
$a Kužel, David, $d 1954- $7 nlk19990073454
700    1_
$a Sláma, Jiří $7 xx0105772
700    1_
$a Fischerová, Daniela $7 xx0074804
700    1_
$a Dundr, Pavel $7 xx0080436
700    1_
$a Freitag, Pavel, $d 1951- $7 xx0018148
700    1_
$a Zikán, Michal, $d 1976- $7 xx0096708
700    1_
$a Pavlišta, David $7 xx0057882
700    1_
$a Tomancová, Věra $7 xx0123263
773    0_
$t Gynecologic Oncology $w MED00001958 $g Roč. 115, č. 1 (2009), s. 46-50
910    __
$a ABA008 $b x $y 2 $z 0
990    __
$a 20110715095048 $b ABA008
991    __
$a 20140328110133 $b ABA008
999    __
$a ok $b bmc $g 864445 $s 729358
BAS    __
$a 3
BMC    __
$a 2009 $x MED00001958 $b 115 $c 1 $d 46-50 $m Gynecologic oncology $n Gynecol Oncol
GRA    __
$a NS10037 $p MZ0
LZP    __
$a 2011-3B09/Bjvme

Najít záznam

Citační ukazatele

Nahrávání dat ...